Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
Investigators at Oregon Health & Science University target cervical cancer
May 7th, 2009
According to a study from the United States, "Cervical cancer and its dysplasia precursors account for significant morbidity and mortality in women worldwide." "Human papillomavirus infection is common, preventable, and now widely accepted as the causative agent with oncogenic potential in the development of cervical cancer. Screening via Papanicolaou testing is critical, and interpretation of test results with knowledge of patient risk factors is imperative," wrote J.B. Warren and colleagues, Oregon Health & Science University. The researchers concluded: "Many evidence-based guidelines for screening, interpretation, and management have been...
Source: Women's Health Weekly (2009-05-07)
|
